Your Web Site
Novo Nordisk says FDA may delay Liraglutide ruling (at Reuters)
yahoo.com 18 hrs agoSTOCKHOLM, Sept 5 (Reuters) - Danish pharmaceuticals group Novo Nordisk (NOVOb.CO: ) said on Friday an assessment by the U.S. Food and Drug Administration of its type 2 diabetes drug Liraglutide is likely to be delayed by...

